Parallel Advisors’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Parallel Advisors’s Portfolio CLBTW Stock Details CLBTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-666	Closed	-$846	–	3502
2023 Q3	$846	Hold	666	–	–	﹤0.01%	3002
2023 Q2	$826	Hold	666	–	–	﹤0.01%	2979
2023 Q1	$573	Hold	666	–	–	﹤0.01%	3077
2022 Q4	$412	Hold	666	–	–	﹤0.01%	3069
2022 Q3	$0	Hold	666	–	–	﹤0.01%	3574
2022 Q2	$1K	Hold	666	–	–	﹤0.01%	2906
2022 Q1	$1K	Hold	666	–	–	﹤0.01%	2884
2021 Q4	$1K	Hold	666	–	–	﹤0.01%	2999
2021 Q3	$1K	Buy	+666	New	+$1.53K	﹤0.01%	2996

Other funds holding CLBTW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

CPM

Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return

DPCM

Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parallel Advisors's CLBTW Position: Q4 2023 in Review

Parallel Advisors sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q4 2023, closing a stake of 666 shares — an estimated $846 sold.

Parallel Advisors first reported a position in CLBTW in Q3 2021 and held it in 9 quarters. The position peaked at $1K in Q2 2022. 19 funds tracked by Wall St. Rank hold CLBTW as of Q4 2023.

Parallel Advisors reported no remaining Cellebrite DI Ltd. Warrants position as of Q4 2023 after selling out during the quarter.
Parallel Advisors sold 666 Cellebrite DI Ltd. Warrants shares in Q4 2023, an estimated $846.
Parallel Advisors first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 9 quarters.
Parallel Advisors's Cellebrite DI Ltd. Warrants position peaked at $1K in Q2 2022.
19 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q4 2023.

Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.